4.6 Letter

Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Rheumatology

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

Hendrik Schulze-Koops et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Letter Clinical Neurology

Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain

Paloma Montero-Escribano et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Letter Rheumatology

B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?

Puja Mehta et al.

LANCET RHEUMATOLOGY (2020)